Trial intelligence / Profile preview

Topical Cannabidiol for Plantar Fasciitis

NCT07776405Phase 2Not yet recruiting

Sponsor
University of Florida
Start
Sep 2026
Primary completion
Mar 2027
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in plantar fasciitis (2 arms), sponsored by University of Florida. Primary endpoints: Immediate pain relief at 10 months, One-month changes in average daily pain score compared to baseline at 1 month and 1 more. Planned start Sep 2026; status: not yet recruiting.

02

Conditions

plantar fasciitis

Beyond the preview

Go deeper on NCT07776405.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07776405.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call